Domov › Rakovina prostaty › Kolumbijský okres › Washington
Klinické štúdie Rakovina prostaty v meste Washington, DC
38 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v meste Washington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Prebieha náborFáza 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collection of Blood From Patients With Prostate Cancer
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Prebieha náborFáza 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Precision-Based Genomics in Prostate Cancer
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Collection of Blood From Patients With Cancer
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Prebieha náborFáza 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Prebieha náborFáza 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prebieha náborFáza 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prebieha náborFáza 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · 11 míľ odtiaľ
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Men at High Genetic Risk for Prostate Cancer
Prebieha náborObservačná štúdia
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
Prebieha náborFáza 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Prebieha nábor
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
Prebieha náborFáza 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Prebieha náborFáza 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · 7 míľ odtiaľ
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prebieha náborFáza 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Prebieha náborFáza 1
- Maryland Oncology Hematology, Silver Spring · 7 míľ odtiaľ
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Prebieha náborFáza 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Prebieha nábor
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
Prebieha náborFáza 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prebieha náborFáza 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · 7 míľ odtiaľ
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Silver Spring · 7 míľ odtiaľ
- Massive Bio SYNERGY-AI site, Bethesda · 7 míľ odtiaľ
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Prebieha náborFáza 3
- George Washington University Medical Center, Washington D.C.
Štúdie Rakovina prostaty v iných mestách
- New York City, NY103 štúdií
- Houston, TX76 štúdií
- Los Angeles, CA61 štúdií
- Boston, MA59 štúdií
- St. Louis, MO46 štúdií
- Chicago, IL45 štúdií
- San Francisco, CA45 štúdií
- Philadelphia, PA44 štúdií
- Baltimore, MD43 štúdií
- Nashville, TN43 štúdií
- Seattle, WA42 štúdií
- Dallas, TX36 štúdií
Iné štúdie v Washington
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc55 štúdií
- Rakovina prsníka46 štúdií
- Metastatická rakovina43 štúdií
- Rakovina pľúc41 štúdií
- Obézita33 štúdií
- Kolorektálny karcinóm29 štúdií
- Kardiovaskulárne ochorenia28 štúdií
- Rakovina močového mechúra26 štúdií
- Akútna myeloidná leukémia24 štúdií
- Rakovina vaječníkov23 štúdií
- Lymfóm23 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.